Deal news: Abbott Laboratories (ABT, Fortune 500) is buying the drug unit of its development partner, Belgian pharmaceutical company Solvay, for about $6.6 million in cash. Abbot shares rose 3%.Speaking of acquisitions, Johnson and Johnson bought an 18% stake in biotech firm Crucell for $444 million as part of a deal to develop a flu vaccine.
Monday, September 28, 2009
Abbott to buy Solvay for $6.6 billion (or million?)
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment